Results 1 to 10 of about 6,394 (171)

Macular Thickness- An Early Predictor of Diabetic Macular Oedema [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Diabetic Macular Oedema (DME) accounts for visual morbidity in about three-fourth of Diabetic Retinopathy (DR) patients. Traditional examination on 90D slit lamp or stereoscopic fundus photograph may not be able to identify early ...
Chandrika Sareddy, Shubha Nagpal, Deepa Muzumdar   +2 more
doaj   +2 more sources

Diabetic Macular Oedema Guidelines: An Australian Perspective

Journal of Ophthalmology, 2023
The number of people living with diabetes is expected to rise to 578 million by 2030 and to 700 million by 2045, exacting a severe socioeconomic burden on healthcare systems around the globe.
Yew Sen Yuen, Jagjit Singh Gilhotra, Michelle Dalton, Jaskirat S. Aujla, Hemal Mehta, Sanj Wickremasinghe, Gurmit Uppal, Jennifer Arnold, Fred Chen, Andrew Chang, Samantha Fraser-Bell, Lyndell Lim, Janika Shah, Ellie Bowditch, Geoffrey K. Broadhead   +14 more
doaj   +3 more sources

Macular oedema as manifestation of diabetic retinopathy

Сахарный диабет, 2017
Diabetes mellitus is the third most dangerous disease of our time preceded by cardiovascular diseases and oncologic pathology. According to the International Diabetes Federation (January 1, 2016), worldwide approximately 415 million people aged 20&ndash ...
Mukharram M. Bikbov, Rinat R. Fayzrakhmanov, Rinat M. Zaynullin, Artur F. Zaynetdinov, Timur R. Gilmanshin, Marat R. Kalanov   +5 more
doaj   +3 more sources

Concentrated triamcinolone acetonide suprachoroidally administered for the treatment of diabetic macular oedema [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2023
Introduction/Objective. Diabetic macular oedema is the accumulation of fluid in the macular tissue leading to its thickening. The aim of the study was to evaluate the efficacy of concentrated triamcinolone acetonide 10 mg / 0.1 ml injection into the ...
Petrović Nenad, Todorović Dušan, Srećković Sunčica, Jovanović Mihailo, Šarenac-Vulović Tatjana   +4 more
doaj   +1 more source

EVALUATION OF DIABETIC AND NON-DIABETIC PATIENTS' MACULAR THICKNESS FOLLOWING CATARACT SURGERY. A PROSPECTIVE CASE-CONTROL STUDY.

Student's Journal of Health Research Africa, 2023
Background:  Diabetes accelerates cataract development. After cataract surgery, optical tissue damage causes problems. Cystoid development causes macular oedema. Edoema thickens the macula and impairs the retinal blood barrier.
Sarika Ratha, Lalita C.S, Shovna Dash, Soumya Kanta Mohanty   +3 more
doaj   +1 more source

Intravitreal Bevacizumab Alone Versus Combined Bevacizumab and Macular Grid Laser Photocoagulation in Diffuse Diabetic Macular Oedema [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Diabetes Mellitus (DM) is a common disease with multiple systemic complications. Diabetic macular oedema is the main threat to vision in patients with diabetic retinopathy, which results from the increased permeability of the inner and ...
Fawaz Al Sarireh, Hamzeh Mohammad Alrawashdeh, Khalid Al Zubi, Khalil Al Salem   +3 more
doaj   +1 more source

Diabetic vitreopapillary traction and macular oedema [PDF]

Eye, 2004
To describe an association between optic disc traction and diabetic macular oedema (DME) unresponsive to laser treatment.A retrospective review of all patients with DME who attended our clinic between September 2001 and November 2003 was undertaken.
M, Karatas, J A, Ramirez, A, Ophir
openaire   +2 more sources

Serous macular detachment in diabetic cystoid macular oedema [PDF]

Acta Ophthalmologica Scandinavica, 2005
Abstract.Purpose:  To define serous macular detachment in patients with diabetic cystoid macular oedema (CME). Methods:  This study involved 78 eyes of 58 patients with diabetic CME. The patients underwent complete ophthalmic examination, fluorescein angiography and optical coherence tomography (OCT).
Hakan, Ozdemir, Murat, Karacorlu, Serra, Karacorlu   +2 more
openaire   +2 more sources

Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study

Health Technology Assessment, 2021
Background: Owing to the increasing prevalence of diabetes, the workload related to diabetic macular oedema and proliferative diabetic retinopathy is rising, making it difficult for hospital eye services to meet demands.
Noemi Lois, Jonathan Cook, Ariel Wang, Stephen Aldington, Hema Mistry, Mandy Maredza, Danny McAuley, Tariq Aslam, Clare Bailey, Victor Chong, Faruque Ghanchi, Peter Scanlon, Sobha Sivaprasad, David Steel, Caroline Styles, Augusto Azuara-Blanco, Lindsay Prior, Norman Waugh   +17 more
doaj   +1 more source

Changing Perspectives in Diabetic Macular Oedema – Recognising and Understanding Chronic Diabetic Macular Oedema [PDF]

European Ophthalmic Review, 2014
The satellite symposium moderated by Usha Chakravarthy entitled ‘Changing Perspectives in Diabetic Macular Oedema: Recognising and Understanding Chronic Diabetic Macular Oedema’ was convened at the 2014 EURETINA Congress. The symposium discussed the multiple processes involved in chronic diabetic macular oedema (DMO) and the use of medications, in ...
Pascale Massin, Michael Diestelhorst, Yit Yang, Albert Augustin, Usha Chakravarthy   +4 more
openaire   +1 more source